此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Apically Positioned Flap vs Rolled Flap for Soft Tissue Management During Implant Second-Stage Surgery

2026年5月12日 更新者:Ohio State University

Peri-Implant Soft Tissue Management During Second-Stage Surgery With Two Different Flap Techniques: A Randomized Controlled Study

Patients are being asked to consider joining a research study that looks at two different ways dentists uncover dental implants during a small gum surgery. To join this study, Patients must have two dental implants that are ready to be uncovered. Both uncovering methods used in this research are normal, safe procedures that dentists already use every day. The purpose of this study is to learn which method helps the gums heal better, stay thicker, and look more natural over time.

If patients decide to participate, the dentist will use one method on one implant and the other method on the second implant so we can compare how each implant heals. The study lasts about one year and includes the uncovering surgery plus scheduled follow-up visits. At these visits, the dentist will gently measure your gums, take pictures, take routine dental X-rays, and use a small camera scanner to check how the gum tissue changes. Patients will also be asked to rate any pain or swelling after surgery.

Patients may have soreness, swelling, or minor bleeding-these are the same risks patients would have during normal implant care. Patients may or may not personally benefit, but the extra monitoring may help us track the healing closely, and patients' participation can help dentists improve care for future patients.

Patients can receive regular implant treatment without joining the study. The goal of this summary is to help you think about the pros and cons and decide what feels right for patients.

研究概览

研究类型

介入性

注册 (估计的)

16

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

研究联系人备份

  • 姓名:Guo-Liang Cheng, DDS, MS
  • 电话号码:6142924641
  • 邮箱:cheng.712@osu.edu

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 成人
  • 年长者

接受健康志愿者

不

描述

Inclusion Criteria:

  1. Patients between the ages of 18-80.
  2. Non-smokers or former smokers with at least a 5-year successful cessation history.
  3. Patients with normal systemic health (ASA-I) or well-controlled/stable systemic conditions (ASA-II), such as diabetes with HbA1c < 7.0%, no recent acute myocardial infarction or cerebrovascular accidents within 6 months, or any contraindication for periodontal or implant surgery.
  4. Patients who had, or plan to have, 2 non-adjacent implants of the same system placed under a two-stage implant protocol.
  5. The diameter discrepancy of the 2 target implants must be less than 1 mm.

Exclusion Criteria:

  1. Current smokers, or smokers who have quit <5 years prior to study entry.
  2. Pregnant or lactating women
  3. Patients with substance or alcohol abuse
  4. Patients with a history of antiresorptive therapy, head and neck radiotherapy, and chemotherapy for malignant tumors
  5. Other systemic conditions or medication affecting wound healing.
  6. Poor plaque control with plaque score > 20%
  7. Active/untreated odontogenic and periodontal infections
  8. Implants placed, or planned to be placed, with one-stage implant protocol.
  9. The diameter discrepancy of the 2 target implants is equal to or greater than 1 mm (≥ 1 mm).
  10. Implants showing signs of early peri-implant bone loss or infection.
  11. Severe loss of keratinized tissue (> 50%) at the implant site
  12. Non-English speaking individuals for studies involving informed consent.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:三倍

武器和干预

参与者组/臂
干预/治疗
有源比较器:Apically Positioned Flap (APF)
During implant second-stage surgery, a crestal incision with vertical releases is used to elevate a flap that is repositioned apically and buccally to increase the width of keratinized tissue around the implant, followed by placement of a healing abutment and suturing.
A flap design used during implant second-stage surgery in which a crestal incision with vertical releases is performed, and the flap is repositioned apically and buccally to increase the width of keratinized tissue around the implant.
实验性的:Rolled Flap Technique (RFT)
During implant second-stage surgery, a full-thickness flap is elevated, and a pedicled connective tissue portion is de-epithelialized and rolled toward the buccal aspect to increase peri-implant soft tissue thickness, followed by placement of a healing abutment and suturing.
A flap design used during implant second-stage surgery in which a pedicled connective tissue portion of the flap is de-epithelialized and rolled toward the buccal aspect to increase peri-implant soft tissue thickness.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Change in Keratinized Tissue Width
大体时间:Baseline (second-stage surgery) to 12 months after surgery
Keratinized tissue width will be measured clinically in millimeters at the mid-buccal aspect of the implant using a periodontal probe at prespecified follow-up visits.
Baseline (second-stage surgery) to 12 months after surgery
Change in Peri-Implant Mucosal Thickness
大体时间:Baseline (second-stage surgery) to 12 months after surgery
Peri-implant mucosal thickness will be assessed by superimposing serial intraoral scan data to quantify changes in buccal soft tissue thickness at implant sites over time.
Baseline (second-stage surgery) to 12 months after surgery

次要结果测量

结果测量
措施说明
大体时间
Pink Esthetic Score (PES)
大体时间:3, 6, and 12 months after second-stage surgery
Peri-implant soft tissue esthetics will be evaluated using the Pink Esthetic Score based on standardized clinical photographs, assessing papilla, tissue contour, color, and texture.
3, 6, and 12 months after second-stage surgery
Change in Peri-Implant Soft Tissue Volume
大体时间:Baseline to 3, 6, and 12 months after second-stage surgery
Three-dimensional soft tissue volume changes will be quantified by superimposing serial intraoral scan data obtained at baseline and follow-up visits.
Baseline to 3, 6, and 12 months after second-stage surgery
Early Wound Healing Index
大体时间:1 and 2 weeks after second-stage surgery
Early wound healing will be assessed using a standardized healing index based on tissue color, bleeding, granulation tissue, and epithelialization.
1 and 2 weeks after second-stage surgery
Plaque Index (PI)
大体时间:1 week, 2 weeks, 1 month, 3 months, 6 months, and 12 months after second-stage surgery
Oral hygiene status will be assessed using the plaque index based on clinical examination at peri-implant sites.
1 week, 2 weeks, 1 month, 3 months, 6 months, and 12 months after second-stage surgery
Modified Sulcular Bleeding Index (mSBI)
大体时间:1 week, 2 weeks, 1 month, 3 months, 6 months, and 12 months after second-stage surgery
Peri-implant soft tissue inflammation will be assessed using the modified sulcular bleeding index during clinical examination.
1 week, 2 weeks, 1 month, 3 months, 6 months, and 12 months after second-stage surgery
Postoperative Pain Score
大体时间:1 and 2 weeks after second-stage surgery
Participant-reported pain will be measured using a visual analog scale (VAS, 0-100), where higher scores indicate greater pain intensity.
1 and 2 weeks after second-stage surgery
Postoperative Swelling Score
大体时间:1 and 2 weeks after second-stage surgery
Participant-reported swelling will be assessed using a visual analog scale (VAS, 0-100), where higher scores indicate greater perceived swelling.
1 and 2 weeks after second-stage surgery
Change in Peri-Implant Bone Level
大体时间:Baseline to 12 months after second-stage surgery
Peri-implant marginal bone levels will be assessed using standardized periapical radiographs and compared between baseline and follow-up.
Baseline to 12 months after second-stage surgery

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (估计的)

2026年6月30日

初级完成 (估计的)

2028年6月30日

研究完成 (估计的)

2028年6月30日

研究注册日期

首次提交

2026年5月12日

首先提交符合 QC 标准的

2026年5月12日

首次发布 (实际的)

2026年5月19日

研究记录更新

最后更新发布 (实际的)

2026年5月19日

上次提交的符合 QC 标准的更新

2026年5月12日

最后验证

2026年5月1日

更多信息

与本研究相关的术语

其他研究编号

  • STUDY20252723

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

未定

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅